Two of Nigeria’s most significant health emergencies carry no fever, no visible wound, and no moment of outbreak. Cancer and hypertension develop over years, inside bodies that feel functional, in communities with no early warning system to speak of. Together, they are quietly redrawing the country’s disease landscape, claiming lives in growing numbers and pressing a healthcare system, already operating beyond comfortable capacity, further toward its limits.
The scale is no longer a matter of projection. According to data from the Global Cancer Observatory, Nigeria recorded approximately 127,763 new cancer cases and 79,542 cancer deaths in 2022 alone. The 2025 State of Health of the Nation Report, released by the Federal Ministry of Health and Social Welfare, confirmed that at least 40 per cent of Nigerian adults now live with hypertension. These are not distant estimates. They are present realities, and the conditions driving them are structural rather than incidental.
A Country Mid-Transition
To understand why non-communicable diseases are surging in Nigeria, it helps to understand the kind of transition the country is currently navigating. Nigeria is urbanising rapidly. Lagos grows at an annual rate of approximately 5.8 per cent, making it one of the fastest-expanding cities on earth. Port Harcourt, Abuja, Kano, and Ibadan are each densifying at pace. This expansion is not simply demographic. It reconfigures how people eat, how they move, how they work, and how they age.
Urbanisation in Nigeria has arrived without the public health infrastructure to absorb its consequences. The shift from diets rich in vegetables, legumes, and unprocessed grains towards processed foods, refined carbohydrates, and high-sodium convenience meals did not unfold gradually. For millions of Nigerians living in dense urban environments, it compressed into a single generation. The same holds for physical activity. Walking and manual labour once shaped the daily rhythms of much of the population; sedentary occupations and motorised transport have since displaced them across urban communities. These changes are not moral failures. They are consequences of economic transition without proportional public health planning.
The result is what researchers describe as an epidemiological transition. Nigeria still carries a substantial burden of infectious diseases and now carries a growing burden of chronic ones alongside them. The double burden is not unique to Nigeria, but few countries face it at this scale, this pace, and this level of healthcare underinvestment. The trajectory points steeply upward. Cancer incidence across Sub-Saharan Africa is projected to nearly double by 2040, with close to 2.1 million cases and 1.4 million deaths forecast across the continent within that period. For a country already carrying the heaviest cancer burden in the sub-region, that projection is not a distant concern. It is an imminent one.
Cancer: Rising Fast, Detected Late
Nigeria ranks first in Sub-Saharan Africa for cancer burden and second across the entire African continent, behind Egypt. That position does not reflect better diagnosis or improved reporting. It reflects actual incidence, driven by population size, shifting risk exposures, and deeply embedded barriers to early detection.
Between 2018 and 2022, Nigeria recorded 269,109 cancer cases, with breast cancer, prostate cancer, cervical cancer, colorectal cancer, and non-Hodgkin lymphoma ranked as the five most common. Breast cancer accounts for approximately 25 per cent of all cancer cases nationally, making it the single most prevalent cancer in the country. Its incidence has climbed steeply over recent decades. Rates roughly doubled between the 1960s and 2000, then doubled again within the single decade that followed. That compression of risk over time is not something demographic change alone can account for. Prostate cancer accounts for 14.1 per cent of all cancer cases nationally and 14.4 per cent of all cancer deaths, making it the leading cause of cancer mortality among men.
Population growth is a direct factor. As Nigeria’s population expands and ages, more people enter the age ranges at which cancer risk concentrates. But the increase in breast cancer incidence among younger women points to something beyond demography. Dietary shifts, hormonal exposures, reduced breastfeeding rates in urban settings, and sedentary patterns each have a documented role.
Cervical cancer sharpens the picture further. It is largely preventable, and yet it remains Nigeria’s third most common cause of cancer death. That persistence directly exposes the inadequacy of screening infrastructure. Prevention demands consistent access to screening, vaccination, and early treatment. None of those conditions holds reliably across the country.
What compounds all of this is the pattern of presentation. A 2025 systematic review and meta-analysis examining Nigerian breast cancer data from 2018 to 2023 found that 76 per cent of cases were classified as advanced at the point of diagnosis. The same analysis noted there has been little measurable improvement in stage at diagnosis since the 1980s. The Lancet Oncology Commission calculated that Sub-Saharan Africa’s mortality-to-incidence ratio for cancer stands at 0.7, compared to 0.3 in high-income regions. More people diagnosed in Nigeria die from cancer than in countries where diagnosis arrives earlier and treatment is more accessible. The gap is not modest.
Late presentation is not simply a product of inadequate infrastructure, though infrastructure is central. Cultural and spiritual beliefs constitute a parallel and largely unaddressed barrier. Research documents a widespread pattern of Nigerians attributing cancer to witchcraft, spiritual punishment, or mystical forces, a pattern that diverts patients towards prayers and traditional remedies before or instead of medical care.
Dr. Nwamaka Lasebikan, Director of Research and Innovation at the National Institute for Cancer Research and Treatment, stated in 2025 that misinformation attributing breast cancer to spiritual attacks is widespread and directly contributes to delayed diagnosis. A published study from northern Nigeria captured the same phenomenon with particular directness, describing cancer there as a condition widely considered “not for hospital.” These beliefs are not a cultural footnote. They are a measurable driver of the late-stage presentation that renders treatment so difficult and so frequently futile.
Nigeria has only 27 cancer treatment centres for a population of 218.5 million. The healthcare budget in 2024 amounted to roughly ₦6,400 per person per year. Against that figure, the cost of cancer diagnosis and treatment is not merely a hardship. It is, for most families, impossible to sustain without catastrophic consequence.
The disease burden, in other words, is not the whole problem. The system that receives it is.
Hypertension: The Condition That Waits
Hypertension announces itself differently from cancer. It is, by clinical description, a silent disease. Blood pressure rarely signals its presence. It does not typically cause visible distress until its complications arrive, and by the time they do, the damage to arteries, kidneys, and the heart may already be irreversible.
In urban clinics across Nigeria, patients regularly present for unrelated complaints only to discover, during routine checks, that their blood pressure is dangerously elevated. For many, this is the first time the condition has been named. It had been present for years, unnoticed and unmanaged, accumulating damage with no announcement.
Over the last two decades, hypertension prevalence in Nigeria tripled. The Nigeria Demographic and Health Survey 2023 to 2024 confirmed that approximately 30 to 40 per cent of Nigerian adults are now living with high blood pressure. Africa carries the highest estimated prevalence of hypertension globally, and Nigeria, as the continent’s most populous nation, drives a significant share of that burden. A national prevalence study using a blood pressure threshold of 140/90 mmHg placed the figure at 45.9 per cent of adults assessed. The variation in estimates reflects differences in methodology. The direction of the trend does not vary at all.
The consequences are severe. Cardiovascular disease claims close to 234,000 lives in Nigeria every year. Hypertension underlies up to 80 per cent of stroke cases in some Nigerian hospital studies, and stroke ranks among the leading causes of death and disability in the country. The connection between unmanaged blood pressure and catastrophic cardiovascular events is not theoretical. It plays out in the lives, and the deaths, of working-age Nigerians in growing numbers.
The awareness, treatment, and control rates for hypertension among Nigerian adults stand at 60 per cent, 34 per cent, and 12 per cent respectively. Those three numbers reveal a particular failure. Awareness has improved, but awareness detached from access to affordable, sustained treatment produces little clinical effect. A 12 per cent control rate means the vast majority of those living with hypertension carry it unmanaged, accumulating cardiovascular risk over years, with no intervention catching up to the damage being done.
High salt consumption, unhealthy diets, tobacco use, and harmful alcohol intake are established primary drivers of rising hypertension. Physical inactivity is consistent across both urban and rural settings. Obesity is rising, particularly among women in urban areas. Financial and occupational stress, concentrated in cities like Lagos, contributes measurably to blood pressure elevation, a connection the evidence supports more firmly than public health messaging has yet reflected.
A pharmacological gap compounds the clinical picture. Antihypertensive medication is effective, but sustained access requires a functioning primary healthcare infrastructure, a reliable medicine supply chain, and either affordable prices or insurance coverage. Nearly 90 per cent of healthcare expenditure in Nigeria is paid out of pocket. For those managing a chronic condition on an irregular income, consistent medication demands a financial calculation that, for many, has no viable answer.
Neither condition arrived randomly. Both are being produced by how Nigeria has urbanised, how its health system is funded, and how chronic disease has been treated as a secondary concern in a country still contending with infectious ones.
The Structural Conditions Behind Both
Cancer and hypertension carry different biology and different clinical profiles. What they share, in the Nigerian context, is exposure to the same set of structural conditions that determine how early they are caught, how effectively they are treated, and how many lives they claim unnecessarily.
Healthcare funding is the foundation of the problem. Under the 2001 Abuja Declaration, African governments committed to allocating 15 per cent of their national budgets to health. Nigeria’s actual government health expenditure ran between 4.22 and 7.23 per cent of the national budget through much of the past decade. That is not a modest shortfall. It explains why 27 cancer treatment centres serve a population of over 218 million, why primary healthcare is too thin to intercept chronic conditions early, and why specialist capacity concentrates in a handful of urban tertiary institutions that most Nigerians cannot reach.
Data collection exposes its own failure. Nigeria only officially declared cancer a notifiable disease in 2024, a decisive move requiring all public and private healthcare institutions to report diagnosed cases to a national registry. Before that, reliable national incidence data was structurally impossible to compile, and planning proceeded on estimation rather than evidence. The figures available today almost certainly undercount true incidence.
What looks like individual dietary choice operates within the same logic. The shift away from traditional diets towards refined, energy-dense, and processed alternatives was shaped by commercial forces: the proliferation of processed foods in urban markets, the decline of traditional cooking practices in younger populations, and the aggressive promotion of energy-dense products in communities where nutritional literacy is limited. Placing the full burden of response on individual behaviour misreads the nature of the transition.
The environmental dimension of this burden rarely receives the analytical attention it warrants. Air pollution in Lagos, Kano, Port Harcourt, and other densely settled cities exposes residents daily to particulate matter linked to cardiovascular disease, respiratory illness, and cancer. Proximity to unregulated dumpsites and open burning sites, a routine condition across many urban and peri-urban communities, brings sustained exposure to carcinogenic materials. Workers across Nigeria’s construction sector, oil and gas operations, and informal manufacturing economy frequently operate without adequate protective equipment or health monitoring. The Niger Delta, where decades of oil extraction have contaminated soil, water, and air across wide areas, presents a specific and well-documented case of environmental carcinogen exposure borne by populations with no institutional protection and no real recourse.
These are structural risk factors, not individual ones.
The economic consequences of these failures reach beyond hospitals. Households managing chronic conditions without insurance face a sustained, compounding financial drain. Working-age Nigerians removed from economic participation by late-stage cancer or unmanaged hypertension represent lost productivity, lost income, and lost caregiving capacity within families. A country losing working-age adults to conditions that were preventable or manageable at earlier stages forfeits more than lives. It forfeits productive capacity, family stability, and economic momentum. Health is not separate from economic development. It underpins it.
Nigeria does hold one structural asset that formal health policy consistently undervalues. Extended family networks mediate care funding, patient transport, treatment adherence, and emotional support across the country. These are functions that chronic disease management depends on and that policy has yet to systematically leverage.
Government Response and Its Limits
Government recognition of the non-communicable disease burden has deepened. The establishment of the National Institute for Cancer Research and Treatment in 2023, the launch of the National Strategic Cancer Control Plan running through 2027, and the designation of cancer as a notifiable disease all represent concrete institutional moves. The NSIA and Lagos University Teaching Hospital Cancer Treatment Centre treated over 10,000 patients between 2019 and 2024, providing radiotherapy, chemotherapy, and advanced brachytherapy sessions. For hypertension, the Hypertension Treatment in Nigeria programme achieved a control rate exceeding 50 per cent among enrolled patients, demonstrating that structured, protocol-driven management at the primary care level can produce results when properly resourced.
These achievements are real. They also demand honest framing.
NICRAT’s own published National Strategic Plan 2023-2027 recorded that the preceding 2018-2022 cancer control programme underperformed against its own targets. That institutional candour is useful, but it tells a sobering story about the distance between stated policy and achieved outcomes. The infrastructure deficit remains enormous, and capacity expansion has not kept pace with a disease burden that continues to grow. The system does not fail suddenly. It yields gradually under pressure.
The trajectory of both conditions will be determined not by whether government acknowledges the problem, which it increasingly does, but by whether that acknowledgement translates into sustained investment, institutional expansion, and primary care reform. Nigeria’s health system currently encounters most of its non-communicable disease patients too late, in conditions too advanced, at a cost few families can absorb.
Reversing that pattern is not a matter of campaigning harder. It requires rebuilding the point of first contact.
Incidence is rising. Detection remains late. Capacity is limited.
That gap is the real diagnosis. The conditions are its symptoms.
